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Coronary spasm is the mechanism most often postulated to explain the rare combination of myocardial
infarction and angiographically normal coronary arteries, although the reported evidence for its role is
circumstantial rather than conclusive. Whereas the importance of thrombosis in myocardial infarction is
uncontested in the presence of significant coronary artery disease, there is little in vivo evidence for thrombosis
in angiographically normal coronary arteries.
Among 11 consecutive patients with acute myocardial infarction undergoing thrombolytic therapy with
recombinant tissue plasminogen activator (rtPA) 3-2±0-7h after onset of chest pain, and angiography
10-2 ±4-5 days later, three young men had normal coronary arteries. Their cases are documented electro-
catdiographically, enzymatically and angiographically. Mean plasma levels of fibrinopeptide A (FPA) and
beta-thromboglobulin (BTG) were clearly elevated before and during rtPA therapy: FPA 52±41 ngml~',
BTG 257 ±46 ng ml~'. They did not differ significantly from corresponding mean plasma levels in the eight
patients with severe coronary artery disease: FPA 67+66 ng ml'1,BTG181 ± 75 ng ml"'.
We conclude that fibrin formation and platelet activation are probably equally important in the early hours
of myocardial infarction, whether or not significant coronary artery disease is present.
Introduction lesions'241. Acute myocardial ischaemia without
coronary atheromatosis can also originate from
Myocardial infarction with angiographically nor-
 a n extreme imbalance between oxygen demand
mal coronary arteries is a rare event and an enigma
 a n d supply or an abnormal haemoglobin-oxygen
that has received much attention in the literature1'"61, dissociation'251
The prevalence of normal or nearly normal coron- Fibrinopeptide A (FPA), cleaved from fibrino-
ary arteries is high, however, in certain subsets of
 g e n b y thrombin1261, is a very sensitive marker of
patients with myocardial infarction, such as in thrombosis in vivo'27'281. Elevated FPA plasma
young women using oral contraceptives and smok-
 l e v e I s h a v e been reported in patients with acute
ing17"91, in young men during or following severe
 myocardial infarction'2*-321, unstable angina'"1
physical exercise"0"1 or in very young
 a n d v e n o u s thromboembolism'341. Similarly, beta-
patients12-12-131. Suggested mechanisms for the thromboglobulin (BTG) plasma levels reflecting
'unproven combination'"1 of myocardial infarction enhanced platelet activation'351 have been shown to
and normal coronary arteries include: coronary ^ elevated in patients with acute myocardial
spasm"4"171, coronary emboli'21, thrombosis with infarction'36371 and unstable angina'37-381,
spontaneous lysis"8191, regression of coronary
 W e measured plasma levels of FPA, BTG and
atheromatosis'20-211, trauma'221, small vessel disease1231 platelet factor 4 (PF4) in 11 consecutive patients
and angiographically unidentifiable coronary ^^
 a c u t e myocardial infarction who underwent
intravenous thrombolytic therapy with rtPA and
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myocardial infarction and significant coronary
artery disease.
Methods
PATIENTS AND MANAGEMENT
Inclusion and exclusion criteria for thrombo-
lytic therapy were according to the European Co-
operative rtPA study139' except for the time lapse
from onset of pain (< 4 h) and anticoagulation that
excluded our patients. 100 mg rtPA (predominantly
single chain material) provided by Boehringer-
Ingelheim, Switzerland, was infused intravenously
over 3 h. All patients underwent biplane left ventri-
culography and selective coronary arteriography
between 5 and 19 (mean 10 ±4-5) days after throm-
bolytic therapy.
COAGULATION AND PLATELET TESTS
Blood samples were taken by careful venepunc-
ture before starting the rtPA infusion and 90 min
later during rtPA therapy, but before initiating
the heparin infusion. They were collected into
precooled sample tubes, containing the follow-
ing anticoagulants (for 9 ml of blood): 1 ml
0-1 02 M citrate, 1 ml cytosin theophyllin adenosin
dipyramidol (CTAD) (Boehringer-Mannheim)
supplemented with 200 ug D-phenyl-prolyl-
arginine-chloromethylketone (PPACK) as throm-
bin inhibitor1401. The blood samples were carefully
mixed, immediately cooled on ice and centrifuged at
4°C/2500g for 30 min within 1 hour of sampling.
The plasma was stored at — 70 °C. A record was
kept of each blood sample in order to identify even-
tual difficulties in sampling and processing.
FPA was determined in our laboratory using a
previously published radioimmunoassay (RIA)1281
with the following modifications: cross-reacting
fibrinogen was eliminated by bentonite absorption
before using the fibrinogen-free supernatant for the
RIA. Free antigen was separated from bound anti-
gen by use of an immobilized second goat-
anti-rabbit antibody (Immunobeads, Bio Rad
laboratories). Previously measured levels of FPA in
15 normal individuals were 1-9 ±0-8 ngml~"[321.
BTG and PF4 were determined by specific
ELISA, both obtained from Boehringer-Mann-
heim, F.R.G. Normal values for BTG are 10-
40ngml~'. These values are comparable to BTG
levels obtained by RIA[41'. PF4 plasma levels were
measured in order to exclude in vitro platelet acti-
vation by venepuncture artefact (normal range:
<10ngml~', a BTG/PF4 ratio <3 indicating in
vitro platelet activation1421.
In addition, blood samples for plasma creatine
kinase/MB levels were taken 8, 12, 16, 24 and 48 h
after the onset of thrombolytic therapy.
Results
PATIENTS WITH NORMAL CORONARY ARTERIES
(GROUP A)
The three cases (numbers 5,9 and 10) with angio-
graphically normal coronary arteries after myo-
cardial infarction are documented separately in
Figs 1-3. All blood samples for FPA and BTG
measurements were taken without difficulty.
Case 5 (Fig. 1)
A young sportsman, 27 years of age and a regular
smoker, had a 4-month history of transient precor-
dial discomfort at rest, but a normal maximal tread-
mill test, suggesting the possibility of spastic angina.
He was admitted with severe nitroglycerin-resistant
chest pain that had begun during an ice-hockey
match. The electrocardiogram showed an acute
inferolateral myocardial infarction. Intravenous
thrombolytic therapy with rtPA was initiated 3 h
15 min after the onset of chest pain. A bradycardiac
nodal rhythm followed by self-limited ventricular
tachycardia/flutter and a sudden relief of chest pain
suggested reperfusion 1 h later. Another short epi-
sode of ventricular tachycardia 2 h after the end of
thrombolytic therapy and a double peaked curve of
creatine kinase/MB plasma levels suggested a re-
occlusion and secondary reperfusion. No further
complication occurred. An inferior Q-wave infarc-
tion evolved subsequently. However, no regional
wall motion abnormality indicative of transmural
myocardial infarction was noted angiographically 5
days after the acute event. The coronary arteries
were normal, except for systolic narrowing of the
left anterior descending artery by myocardial
bridging. This abnormality, however, could not be
responsible for the acute ischaemic event in the
inferior myocardial region, nor probably for the
history of transient precordial discomfort at rest,
since the diastolic diameter of the left anterior des-
cending artery was also normal. FPA plasma levels
were elevated (6-3 ngml~' and 39-4 ng ml"1), indi-
cating thrombosis before and 90 min after initiation
of thrombolytic therapy. The corresponding high
BTG plasma levels (172 and 256ngml~') and
normal PF4 levels (10 and 29 ng ml"1) documented
markedly enhanced platelet activation in vitro with-
out activation.
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Figure 1 27-year-old man with acute infer-
ior myocardial infarction undergoing throm-
bolytic therapy with rtPA 3-3 h after onset of
chest pain. See text for details.
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Figure 2 43-year-old man with acute
anterior myocardial infarction undergoing
intravenous thrombolytic therapy with rtPA
3-5 h after onset of chest pain. See text for
details.
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Figure 3 38-year-old man with acute infero-
posterior myocardial infarction undergoing
intravenous thrombolytic therapy with rtPA
3-4 h after onset of chest pain. See text for
details.
Table 1 Pertinent data on 11 patients with acute myocardial infarction and angiographically normal (group A) or significantly diseased (group B) coronary arteries after
thrombolysis
Case Sex Age
(yr)
Time onset
pain toTL
(h) of MI
group A (normal coronary arteries)
5
9
10
Mean
±SD
m
m
m
27
43
38
36
8 2
3-3
3-5
3-4
3-4
0 1
inf-lat
ant
inf-post
group B (significant coronary artery disease)
1
2
3
4
6
7
8
11
Mean
±SD
m
m
m
m
m
f
m
m
50
35
62
55
49
64
40
49
50-5
9-9
4
2
3-6
2-9
4
2-7
3-7
2-2
31
0-8
inf-lat
inf-post
inf-post
inf-post
inf-post
ant-lat
ant-lat
ant
CK/MB-peak
(hours from
onset TL)
1680/91 (12 h)
1652/87 (20 h)
2230/175(8 h)
2868/169 (6 h)
2259/145
594/47
3255/500 (8 h)
744/87 (8h)
2193/145 (12h)
771/83 (16h)
1705/175(12 h)
1371/183(8 h)
5250/442 (8 h)
639/93 (8h)
1991/213
1585/164
5
19
10
11-3
7
5
9
16
8
8
11
14
7
9-8
3-7
CAD
0
0
0
1VD
1VD
3VD
2VD
2VD
1VD
1VD
1VD
Angiography
Patency Res. Sten.
IRA
+ (RCA)
+ (LAD)
+ (CX)
+ (RCA)
+ (RCA)
+ (RCA)
+ (RCA)
+(RCA)
+ (LAD)
+ (LAD)
+ (LAD)
IRA
0%
0%
0%
55%
90%
90%
65%
90%
99%
80%
99%
83%
16%
Wall motion in
jeopard, region
normal LV
(a)ap
ainf
a inf-post
(h)inf
hinf
normal LV
h-a inf
dap
a-d ant-ap
normal LV
FPA
before during
TL(ngmg- ' )
6-3 39-4
15-3 56-4
73-4 119-2
51-7
41-4
17 9 — *
235-8 63-6
• *
16-8 1021
30-7 155-2
68-9 700
51-4 410
1-6** 130
66-8
65-7
BTG
before during
TL(ngm|- ' )
172
284
253
159
287
•
43
100
198
167
233
256
304
275
257
46
*
188
*
131
193
263
102
289
181
75
PF4
before during
TL(ngml- ' )
10
199
111
44
183
*
3
12
67
43
143
29
215
153
*
103
*
40
42
139
10
190
•data eliminated because of spurious elevation by blood sampling difficulty; "heparin pretreatment; a = akinesia, ant = anterior, ap = apical, BTG = beta-thromboglobulin,
CAD = coronary artery disease, CK/MB = creatine kinase/MB-fraction, CX = circumflex artery, d = dyskinesia, ECG = electrocardiogram, FPA = fibrinopeptide A, h =
hypokinesia, inf=inferior, IRA = infarct-related artery, LAD = left anterior descending artery, lat = lateral, MI = myocardial infarction, PF4 = platelet factor 4, post =
posterior, RCA = right coronary artery, Res. Sten. = residual stenosis, TL = thrombolysis, 1,2,3-VD = 1,2,3-vessel disease.
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Case 9 (Fig. 2)
A 43-year-old man, a heavy smoker without
history of angina, was admitted with severe nitro-
glycerin-resistant chest pain and electrocardio-
graphic signs of an acute anterior myocardial
infarction. Intravenous thrombolytic therapy with
rtPA was initiated 3 h 30 min after onset of pain.
Ventricular extrasystoles in salvos 50 min later were
interpreted as a reperfusion arrhythmia, since chest
pain abruptly disappeared. No complication oc-
curred. Peaking in creatine kinase/MB plasma
levels was early. An anterior Q-wave infarction,
with loss of R-potentials from VI to V4, developed.
Angiography, 19 days after the acute event, showed
a localized but distinct apical akinesia, attributable
to a long left anterior descending artery. Coronary
arteries, however, were normal. FPA plasma levels
were elevated (15-3 and 56-4 ng ml"1) before and
during thrombolytic therapy, as were BTG plasma
levels (284 and 304 ng ml"' respectively), indicating
thrombosis and platelet activation. Since PF4 levels
(199 and 215 ngml"1) were also elevated, however,
additional platelet activation in vitro had to be
presumed in this case.
Case 10 (Fig. 3)
A 38-year-old man with no history of angina was
admitted with nitroglycerin-resistant chest pain
that had begun during a soccer game. With typical
electrocardiographic signs of acute inferoposterior
myocardial infarction, intravenous thrombolytic
therapy with rtPA was started 3 h 25 min after the
onset of chest pain. The pain diminished gradually
during therapy. No reperfusion arrhythmia was
noted. Creatine-kinase MB plasma levels peaked
very early. An inferior Q-wave infarction evolved
within 24 h. No complication occurred. Angiogra-
phy 10 days later confirmed an inferior akinesia cor-
responding to the posterior descending branch of a
dominant circumflex artery. However, except for
minor wall irregularities, the coronary arteries were
normal. FPA (73-4 and 119-2ngml-') and BTG
(172 and 256 ngml"1) plasma levels were markedly
elevated, documenting fibrin formation and platelet
activation in vivo with some platelet activation in
vitro (PF4 levels 111 and 153ngmr') .
patients with normal coronary arteries in Table 1.
The mean age was higher (50-5 ± 10 vs 36 ± 8 years).
All patients were admitted with typical clinical and
electrocardiographic signs of acute myocardial
infarction (five inferoposterior, three anterolateral).
Intravenous thrombolytic therapy with rtPA was
initiated between 2 and 4h (mean 3-1+0-8h vs
3-4 ±0-1 h in group A) after the onset of chest pain,
which disappeared in all but one case, while arrhyth-
mias suggesting reperfusion were noted in 4 out
of 8 cases. Peaking of creatine kinase plasma levels
occurred within 12 h in 7 out of 8 patients. Q-wave
infarction developed in all patients. Angiography
9-7 + 3-7 days after the acute event revealed a nor-
mal left ventricle in two cases treated very early,
only small hypokinetic zones in two cases, and
akinetic or dyskinetic regions corresponding with
the electrocardiographic infarct site in four cases.
The infarct-related artery was patent in all patients,
with a mean residual stenosis of 84+15%. FPA
(mean 66-8 ±65-7 ng ml"') and BTG (mean
181 ±75 ng ml"1) plasma levels were elevated
before and during thrombolytic therapy in all
patients but one (case 11) whose first FPA value was
low because of spurious heparin. Three out of 16
FPA values were not taken into account because of
sampling difficulties. In 5 out of 13 blood samples
a BTG/PF4 ratio <3 indicated some platelet
activation in vitro'421.
Discussion
PREVALENCE OF NORMAL ANGIOGRAPHY AFTER
MYOCARDIAL INFARCTION
The prevalence of angiographically normal
coronary arteries after myocardial infarction is 1-
4% according to bigger series'13'431. No significant
coronary stenosis or zero vessel disease is found
in 7-19% of postinfarction patients'4'I3-2C). Very
young patients'13', however, especially women
taking oral contraceptives and smoking*7""9'19' and
young men who sustain myocardial infarction
during or immediately following severe physical
exercise"01" have high prevalence (30-45%) of
angiographically normal or insignificantly diseased
coronary arteries.
PATIENTS WITH SIGNIFICANT CORONARY ARTERY
DISEASE (GROUP B)
The pertinent data and results of patients with
significant coronary artery disease after a first
myocardial infarction are compared with those of
CORONARY SPASM
Spasm is the mechanism most often postulated
to explain the combination of myocardial infarc-
tion and angiographically normal coronary arter-
ies'14"17'431, although the reported evidence for its
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role is circumstantial rather than causal. Among
679 young survivors of myocardial infarction
undergoing angiography, Gohlke et a/.'131 found 25
patients with normal coronary arteries, 32 with
non-significant (< 50%) lesions and 112 withunifo-
cal disease; none of these patients had a history of
repeated angina at rest of the Prinzmetal type prior
to myocardial infarction. Oliva et al. demonstrated
coronary spasm angiographically in six patients
early after acute myocardial infarction1'4', but
the spasm consistently occurred at the site of a
severe coronary lesion, whereas no spasm was
demonstrated in two cases of myocardial infarc-
tion and normal coronary arteries'3'. Vasospasm
has been incriminated in myocardial infarction
during or immediately following vigorous
excercise110'.
The success of early thrombolytic therapy has
established the great importance of thrombosis
compared with spasm in myocardial infarction.
Rentrop et al. demonstrated the negligible effect of
intracoronary nitroglycerin very early after the
onset of chest pain'44'. Vasoconstriction, however,
might play a role in reocclusion during thrombo-
lytic therapy1451.
Markers of platelet activation do not specifically
indicate vasospasm, since aggregating platelets may
exert their effect by mechanical obstruction, enhan-
cement of thrombosis or thromboxane A2-
mediated vasoconstriction. Our measured BTG
levels document platelet activation in patients with
acute MI whether significant coronary artery dis-
ease is present or not. Compared with plasma levels
measured between 6 and 32 h after the onset of
infarction (64 ±21 ngmr"321), the levels of BTG
measured between 2 and 4 h after onset of chest pain
were substantially higher. This might reflect a
higher platelet activity in the early hours of myocar-
dial infarction. Patients with normal coronary
arteries had higher BTG levels than patients with
significant coronary disease (257 ±45 vs
181 ±75 ng ml"'). Whether this corresponds to
more spastic activity in agreement with Ogasawara
et a/.'4*1 remains speculative in view of the small
group size in our study.
CORONARY THROMBOSIS
The causal role of thrombosis in acute myocar-
dial infarction and unstable angina with underlying
significant coronary artery disease is hardly con-
tested today. In vivo evidence is based on angiogra-
phy147'481, angioscopy149', elevated plasma levels of
fibrinopeptide A'29"33' and cross-linked fibrin degra-
dation products'50-51', and the success of early
thrombolytic therapy.
To our knowledge, evidence of a direct connec-
tion between angiographically normal coronary
arteries and in vivo markers of thrombosis has not
been provided so far. Elevated plasma levels of
fibrinopeptide A measured as early as 3-2 ±0-7 h
after the onset of chest pain in patients with enzy-
matically and electrocardiographically evolving
myocardial infarction suggest a causal role of
thrombosis. Since FPA levels in patients with nor-
mal coronary arteries after thrombolytic therapy
are not different from levels in patients with signifi-
cant residual coronary disease, it might be assumed
that thrombosis was the mechanism of coronary
occlusion in both groups. The success of throm-
bolytic therapy and the failure of previously
given nitroglycerin in all patients support this
assumption.
On the other hand, one cannot exclude the possi-
bility that myocardial ischaemia or necrosis per
se, by mechanisms so far not elucidated, such as
endothelial damage in the ischaemic territory,
may be responsible for the activation of both
coagulation and platelets'381. A small intracoronary
thrombus may not be the sole explanation for the
high FPA plasma levels measured. Ischaemia would
then be not only the consequence but also a possible
cause of further fibrin formation. Elevated FPA
levels in unstable angina'33'38' in contrast to stable
angina'37-38' may either favour the hypothesis that
intracoronary thrombosis also plays a major role in
transient ischaemic episodes at rest, commonly
interpreted as coronary spasm, or indicate that
severe ischaemia per se activates coagulation and
platelets.
Plasma levels of FPA measured between 2 and
4 h after the onset of chest pain were significantly
higher than our previously published levels'30-32',
which were measured between 6 and 32 h after
the onset of infarction in non-heparinized
patients. This might reflect a time-dependent
decrease of thrombotic activity in acute myocar-
dial infarction.
Absence of angiographically detectable coronary
lesions does not imply a 'normal' coronary artery.
Early endothelial cell damage without visible
obstruction might have important sequelae, which
have been called 'rapid progression of coronary
artery disease'16'. Platelet deposition on such an
endothelial lesion, leading to intense coronary
spasm of sufficient duration to provoke stasis and
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finally, thrombosis, is a sequence of events postu-
lated to explain myocardial infarction with angic-
graphically normal coronary arteries'6'52'531. A
reduced activity and enhanced inhibition of endo-
genous tissue plasminogen activator in patients
with myocardial infarction without visible coron-
ary artery disease154' might, however, lead to
thrombosis without preceding spasm.
Finally, FPA is not a specific marker of coronary
thrombosis, but could also reflect left ventricular,
venous or extravascular fibrin generation. How-
ever, none of our three young patients with normal
coronary arteries had a left ventricular aneurysm,
atrial enlargement or fibrillation, signs of venous
stasis or a central catheter. The venepuncture was
done with extreme caution and blood samples
obtained without difficulty. Extracoronary fibrin
formation therefore seems improbable.
Conclusion
Myocardial infarction occurs in spite of angio-
graphically normal coronary arteries. Fibrin for-
mation and platelet activation are of crucial
importance whether a significantly diseased or an
apparently normal coronary artery occludes, as
shown by equally elevated plasma levels of fibrino-
peptide A very early after the onset of chest pain, the
ineffectiveness of nitroglycerin and the efficacy of
thrombolytic therapy.
While coronary spasm alone has not been
shown conclusively to be responsible for myocar-
dial infarction, an adjunctive role cannot be
excluded. High beta-thromboglobulin plasma
levels indicate a marked enhancement of platelet
activity in the early hours of myocardial in-
farction, whether significant coronary disease is
present or not.
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